Fuji Pharma Co., Ltd.
Notice on Revision of Interim Dividend Forecast for the Fiscal Year Ending September 2026 (62nd Term)
The interim dividend forecast for the fiscal year ending September 2026 has been revised to 23.00 yen per share. This is an increase from the previous forecast of 21.00 yen, with the full-year dividend projected at 49.00 yen.
Key Figures
- Interim Dividend Forecast: 23.00 yen (Increased from 21.00 yen)
- Year-end Dividend Forecast: 26.00 yen (Unchanged from previous forecast)
- Full-year Dividend Forecast: 49.00 yen (Increased from 47.00 yen)
AI要約
Overview of Dividend Forecast Revision
Fuji Pharmaceutical Industry Co., Ltd. has raised its interim dividend forecast for the fiscal year ending September 2026 from 21.00 yen to 23.00 yen per share. The year-end dividend forecast remains unchanged at 26.00 yen, bringing the full-year dividend forecast up from 47.00 yen to 49.00 yen. This revision reflects the company’s basic policy of stable and continuous shareholder returns, aiming for a payout ratio of 30% based on operating income, supported by steady sales of core products and consideration of financial soundness.
Shareholder Return Policy and Future Outlook
The company adopts a progressive dividend policy and is committed to maintaining stable dividends. The recent dividend forecast revision was decided following a careful assessment of financial conditions and business environment. The company intends to continue shareholder returns based on ongoing business performance while noting that future dividends may fluctuate due to various factors.
Fuji Pharmaceutical Industry Co., Ltd.
Company overview · Stock price · Financial data · All IR
